Contributions of Liquid-Based (Papanicolaou) Cytology and Human Papillomavirus Testing in Cotesting for Detection of Cervical Cancer and Precancer in the United States.
CONCLUSIONS: Analysis of 9-year cotest results from a national reference laboratory confirms the value of LBC element in cotesting. This supports that LBC/HPV cotesting enhances screening for the identification of CxCa in women 30 years and older, more so than LBC or HPV alone within cotesting.
PMID: 32637991 [PubMed - as supplied by publisher]
Source: American Journal of Clinical Pathology - Category: Pathology Authors: Kaufman HW, Alagia DP, Chen Z, Onisko A, Austin RM Tags: Am J Clin Pathol Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | Cytology | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Laboratory Medicine | Papanicolaou (Pap) Smear | Pathology | USA Health | Women